Statement: appendix neuroendocrine tumor pm1a tnm finding v8 is appendix neuroendocrine tumor with metastasis confined to liver. (from ajcc 8th ed.) Infections were the most common adverse events recorded in the primary trial.
Primary_evidence: Adverse Events 1:   Total: 5/55 (9.09%)   Infection 2/55 (3.64%)   Pain * 1/55 (1.82%)   Muscle Weakness * 1/55 (1.82%)   Dyspnea 1/55 (1.82%)